Career Enhancement Program

职业提升计划

• 批准号: 8999527
• 负责人: GARY E GALLICK
• 金额: $ 7.52万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-02 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8999527
• 关键词: Applications Grants; Area; Award; Cancer Biology; Cancer Center; Cancer Research Project; Clinical; Communication; Critiques; Degree program; Development; Discipline; Doctor of Philosophy; Doctor' s Degree; Educational process of instructing; Electronics; Ensure; Evaluation; Faculty; Funding; Genitourinary system; Goals; Grant Review; Guidelines; Human; Individual; Institution; K-Series Research Career Programs; Laboratories; Laboratory Scientists; Leadership; Malignant neoplasm of prostate; Medical Oncologist; Mentors; Mentorship; Methods; Minority; Modification; Peer Review Grants; Physicians; Pilot Projects; Population; Principal Investigator; Process; Program Evaluation; Program Research Project Grants; Publications; Qualifying; Records; Recruitment Activity; Reporting; Research; Research Personnel; Research Project Grants; Schools; Science; Scientist; Series; Statistical Data Interpretation; Talents; Technical Expertise; Techniques; Texas; Training; Translational Research; United States National Institutes of Health; Universities; Woman; Work; Writing; anticancer research; base; career; educational atmosphere; experience; innovation; interest; meetings; member; organizational structure; programs; response; skills; success; translational study; web site

PROJECT SUMMARY (Career Enhancement Program) The goal of the Career Enhancement Program (CEP) of the MD Anderson Cancer Center Prostate Cancer SPORE (Prostate Cancer SPORE) is to develop a cadre of investigators dedicated to translational studies of human prostate cancer. It is directed by Dr. Gary E. Gallick and co-directed by Dr. Christopher J. Logothetis. The program will: 1) recruit innovative entry-level scientists to the Prostate Cancer SPORE to enhance the overall translational research capability of the SPORE and bring new techniques and talent to our program; 2) help these individuals develop the intellectual and technical skills required to be productive investigators in translational prostate cancer research; 3) teach these individuals basic principles of cancer biology not commonly included in clinical training or doctoral degree programs; and 4) guide the entry-level scientists in the development of competitive grant proposals in the area of translational prostate cancer research. The unique educational environment at MD Anderson will ensure that these goals will be met. At least two Career Enhancement awardees will be selected annually during the active funding period from qualified candidates within and outside MD Anderson who respond to a SPORE solicitation based on the defined criteria. Special emphasis will be placed on recruiting qualified women and members of minority populations whenever possible. In response to the previous critique, Dr. Logothetis will be actively involved in recruiting qualified physician/scientists to increase the number of MDs obtaining CEPs. Mentorship training will include principles of cancer biology, scientific methods, statistical analysis, biomedical communications, and strategies necessary to become successful in translational prostate cancer research. Several courses in The University of Texas Graduate School of Biomedical Sciences at Houston that encompass these disciplines are available to CEP recipients. The CEP recipients will be evaluated annually, and the selection process and training will be modified when appropriate. In addition, “upward” evaluation by recipients to their mentors will also occur annually, with modifications to the program made, as necessary, in response to input of CEP recipients (see Appendix “CEP Pilot Project Review Form” and “CEP Evaluation Form” for evaluation criteria). Nine Career Development awards (now Career Enhancement awards) have been funded by the Prostate Cancer SPORE. Investigators receiving CDP awards wrote 53 publications. A total of 25 externally reviewed grant applications were funded. Of note, Dr. Hui-Kuan Lin, a CDP awardee, will submit a Developmental Research Program (DRP) project to the SPORE, reflecting the synergistic relationship between the CEP and DRP mechanisms. Dr. Ana Aparicio, genitourinary medical oncologist, is a CEP awardee.

项目摘要（职业增强计划） MD安德森癌症中心前列腺癌的职业增强计划（CEP）的目标 孢子（前列腺癌孢子）是要开发一组研究人员，致力于翻译研究 人前列腺癌。它由加里·盖利克（Gary E. Gallick）博士执导，由克里斯托弗·J·洛格蒂斯（Christopher J. Logothetis）博士共同执导。 该计划将：1）招募创新的入门级科学家到前列腺癌孢子以增强 总体翻译了孢子的研究能力，并为我们的计划带来了新的技术和人才； 2） 帮助这些人发展成为产品调查人员所需的智力和技术技能 翻译前列腺癌研究； 3）教这些人癌症生物学的基本原理不是 通常包括临床培训或博士学位课程； 4）指导入门级科学家 在翻译的前列腺​​癌研究领域的竞争赠款建议的发展。这 MD Anderson的独特教育环境将确保实现这些目标。至少两个职业 提高奖项将在合格候选人的积极资助期间每年选择 在MD安德森（MD Anderson）内部和外部，他们根据定义的标准对孢子的招标做出了回应。特别的 无论何时，都将重点放在招募合格妇女和少数民族的成员上 可能的。为了响应以前的Bitaryque，Logothetis博士将积极参与招聘合格的 医师/科学家增加获得CEP的MD的数量。指导培训将包括原则 癌症生物学，科学方法，统计分析，生物医学通信和策略 在翻译的前列腺​​癌研究中取得成功的必要条件。大学的几门课程 休斯顿的德克萨斯州生物医学科学研究生院包括这些学科 CEP收件人。 CEP收件人每年将进行评估，选择过程和培训将是 在适当时修改。此外，收件人对导师的“向上”评估也将发生 每年，根据需要对程序进行修改，以应对CEP收件人的输入（请参阅 附录“ CEP Pilot项目审查表格”和“ CEP评估表”的评估标准）。 九个职业发展奖（现在是职业增强奖）已由前列腺资助 癌症孢子。获得CDP奖的调查人员撰写了53个出版物。总共25个外部审查 赠款申请得到了资助。值得注意的是，CDP获奖者Hui-Kuan Lin博士将提交发展 研究计划（DRP）项目向孢子进行了反映，反映了CEP与 DRP机制。 Genitiourinary Medical肿瘤学家Ana Aparicio博士是CEP获奖者。